Together, our results provide support for a model whereby miR-620 targets HPGD, resulting in accumulation of HPGD's substrate, PGE2, and signaling by PGE2 through the EP2 receptor results in cancer radiation resistance (Figure 7). This evidence concerns the gene HPGD and cancer.